Ethnicity and risks of severe COVID-19 outcomes associated with glucose-lowering medications: a cohort study.
Diabetes, obesity & metabolism 2022
Zaccardi F, Tan PS, Coupland C, Shah BR, Clift AK, Saatci D, Patone M, Griffin SJ, Dambha-Miller H, Khunti K, Hippisley-Cox J
DOI : 10.1111/dom.14872
PubMed ID : 36099041
PMCID :
URL : https://onlinelibrary.wiley.com/doi/10.1111/dom.14872
Abstract
Ethnicity and risks of severe COVID-19 outcomes associated with glucose-lowering medications: a cohort study.